Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Nightingale Health

2.14 EUR

+0.47 %

4,678 following

HEALTH

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Investor consensus
Compare
+0.47 %
-9.92 %
-17.88 %
-22.08 %
-25.87 %
-23.20 %
+93.04 %
-
-58.54 %

Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.

Read more
Market cap
130.1M EUR
Turnover
87.23K EUR
P/E (adj.) (26e)
-7.84
EV/EBIT (adj.) (26e)
-5.34
P/B (26e)
2.47
EV/S (26e)
11.76
Dividend yield-% (26e)
-
Coverage
Recommendation
Reduce
Target price
2.50 EUR
Updated
2025-09-19
Disclaimer
Antti Siltanen
Antti Luiro
Antti Luiro, Antti Siltanen
Show more
Latest research

Latest analysis report

Released: 2025-09-19

Latest extensive report

Released: 2025-06-13

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5/3
2026

Interim report Q2'26

Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Another welfare services country is piloting Nightingale's technology
Analyst Comment2 hours ago by
Antti Luiro, Antti Siltanen

Another welfare services country is piloting Nightingale's technology

The North Karelia wellbeing services county is piloting Nightingale's blood analysis technology.

Nightingale Health
Press release7 hours ago

North Karelia Wellbeing Services County adopts Nightingale Health’s disease risk assessment as part of public healthcare in Finland

Nightingale Health
New study on benefits of Nightingale blood test in identifying cardiovascular disease risk
Analyst Comment11 hours ago by
Antti Luiro, Antti Siltanen

New study on benefits of Nightingale blood test in identifying cardiovascular disease risk

A new study shows that the company's blood test can improve the detection of risk factors for heart attacks and strokes.

Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press releaseyesterday

Landmark study: Nightingale Health’s blood test can improve prevention of heart attacks and strokes by 44% compared to current clinical practice

Nightingale Health
Life Science Companies as Investments | Life Science Night Dec. 9, 202514:40
Video12/16/2025, 7:30 AM

Life Science Companies as Investments | Life Science Night Dec. 9, 2025

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia TechnologiesBioretecBiohitFaron PharmaceuticalsModulightNexstimOrionBittiumDetection TechnologyOptomedRevenio GroupNightingale HealthHerantis PharmaNanoform Finland
Changes in Nightingale’s management team continue
Analyst Comment12/15/2025, 7:59 AM by
Antti Luiro, Antti Siltanen

Changes in Nightingale’s management team continue

In light of the news, Nightingale is rebuilding its management team to better accelerate growth in its healthcare business.

Nightingale Health
Regulatory press release12/12/2025, 12:55 PM

Nightingale Health Plc restructures Management Team to accelerate healthcare business growth

Nightingale Health
Nightingale's CFO departs suddenly
Analyst Comment12/9/2025, 5:53 AM by
Antti Luiro, Antti Siltanen

Nightingale's CFO departs suddenly

The rapid change came as a surprise to us and appears to have occurred at the company's initiative, although the exact reasons remain unclear due to the concise announcement.

Nightingale Health
Regulatory press release12/8/2025, 8:35 AM

Change in Nightingale Health Plc’s Management Team

Nightingale Health
Nightingale expands its strategic partnership with Terveystalo
Analyst Comment11/27/2025, 9:12 AM by
Antti Luiro

Nightingale expands its strategic partnership with Terveystalo

With the new agreement, Nightingale's blood analysis technology will be made available to all Terveystalo customer groups, whereas previously it has mainly been used in health check-ups for occupational health customers.

Nightingale Health
Press release11/26/2025, 9:00 AM

Terveystalo and Nightingale Health deepen strategic partnership – preventive healthcare available to all Terveystalo customers in Finland

Nightingale Health
Press release11/20/2025, 8:00 AM

Nightingale Health enables access to world’s largest metabolomics dataset through UK Biobank collaboration

Nightingale Health
Regulatory press release11/6/2025, 3:10 PM

Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc

Nightingale Health
Nightingale strengthens its research offering through strategic partnership
Analyst Comment11/5/2025, 2:59 PM by
Antti Luiro, Antti Siltanen

Nightingale strengthens its research offering through strategic partnership

Through this partnership, Nightingale will integrate Alamar's brain health proteomics technology into its multiomics offering.

Nightingale Health
Press release11/5/2025, 10:50 AM

Nightingale Health partners with Alamar Biosciences to expand its unique multiomics offering with ultra-sensitive proteomics for brain health

Nightingale Health
Regulatory press release10/2/2025, 12:30 PM

Notice to the Annual General Meeting of Nightingale Health Plc

Nightingale Health
Regulatory press release10/2/2025, 6:00 AM

Nightingale Health’s Annual Report for financial year 2024–2025 has been published

Nightingale Health
Analyst Comment9/26/2025, 9:57 AM by
Antti Siltanen

USA införde 100 % tullar på läkemedel – effekterna på europeiska företag fortfarande oklara

Vita huset meddelade på torsdagskvällen nya tullar på läkemedel och vissa andra produkter.

OrionHerantis PharmaFaron PharmaceuticalsBioretecNexstimAiforia TechnologiesBiohitNightingale HealthModulightRevenio GroupOptomed
Nightingale’s service expands again with a new risk prediction
Analyst Comment9/26/2025, 7:16 AM by
Antti Luiro

Nightingale’s service expands again with a new risk prediction

Nightingale Health announced on Thursday the launch of a new risk detection tool that detects a high risk of dangerously high levels of lipoprotein (a), also known as Lp(a).

Nightingale Health
Press release9/25/2025, 9:10 AM

Breakthrough in cardiovascular disease risk assessment – Nightingale Health to offer Lp(a) risk detection as part of its routine health check

Nightingale Health
Forum discussions
Press Release New wellbeing services county joins – North Karelia adopts disease risk identification as part of public healthcare 18.12.2025 at 15:00 Nightingale Health Nightingale Health Plc | Press Release | 18.12.2025 at 15:00:00 EET The North Karelia wellbeing services county...
7 hours ago
by TO
15
Interpreted from the original publication with Copilot’s assistance: Traditional cholesterol measurements: LDL, HDL, triglycerides, sometimes ApoB and ApoA1, describe only a part of lipid metabolism. Reference values: are based on population-level studies. For example, LDL < 3 mmol...
yesterday
by Jussi Pitkonen
14
Press Release Significant Study: Nightingale Health’s Blood Analysis Helps Prevent 44% More Heart Attacks and Strokes Compared to Current Healthcare Practice December 17, 2025 Nightingale Health Nightingale Health Plc | Press Release | December 17, 2025 at 09:30:00 EET An independent...
yesterday
by TO
13
Inderes Uusi tutkimus Nightingalen verianalyysin hyödyistä sydän- ja... Uuden tutkimuksen mukaan yhtiön verianalyysi voi parantaa sydäninfarktien ja aivohalvausten riskintunnistusta.
12 hours ago
by Pertti
8
Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction. European Heart Journal (2025), December 15 https://doi.org/10.1093/eurheartj/ehaf947 It is also worth reading the publication itself. In this, Nightingale’s blood value measurement was indeed...
1 hour ago
by Homeros
6
a new North Karelia project?.. In my opinion, a good example of what NH’s method can aim for in Finland and similarly elsewhere in aging Western countries. The number of people needing care is increasing, the number of funders is decreasing, and treatments also seem to be getting...
5 hours ago
by Jussi Pitkonen
4
AI also says that there are currently over 7,000 unemployed people in South Karelia. This is quite a decent income for NG again, if all these individuals receive this service, say, within the next year, and one sample costs, for example, a hundred. A tidy turnover quickly accumulates...
42 minutes ago
2
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.